Argininosuccinic	B:C0268547
Acid	I:C0268547
Lyase	I:C0268547
Deficiency	I:C0268547
Missed	O
by	O
Newborn	B:C0027617
Screen	I:C0027617
.	O

Argininosuccinic	B:C0268547
acid	I:C0268547
lyase	I:C0268547
(	I:C0268547
ASL	I:C0268547
)	I:C0268547
deficiency	I:C0268547
,	O
caused	O
by	O
mutations	B:C0026882
in	O
the	O
ASL	B:C1412582
gene	I:C1412582
(	O
OMIM	B:C0950133
:	I:C0950133
608310	I:C0950133
)	O
is	O
a	O
urea	B:C0597619
cycle	I:C0597619
disorder	B:C0012634
that	O
has	O
pleiotropic	B:C2936488
presentations	I:C2936488
.	O

On	O
the	O
mild	O
end	O
,	O
ASL	B:C0268547
deficiency	I:C0268547
can	O
manifest	O
as	O
nonspecific	O
neurocognitive	B:C1867987
abnormalities	I:C1867987
without	O
readily	O
identifiable	O
signs	O
to	O
differentiate	O
it	O
from	O
other	O
causes	O
of	O
intellectual	B:C3714756
disability	I:C3714756
or	O
learning	B:C0751265
disabilities	I:C0751265
.	O

Dietary	B:C0012159
management	I:C0012159
and	O
arginine	B:C0003765
supplementation	B:C1261361
,	O
if	O
initiated	O
early	O
,	O
may	O
ameliorate	O
symptoms	B:C1457887
.	O

Because	O
of	O
the	O
nonspecific	O
nature	O
of	O
the	O
symptoms	B:C1457887
and	O
the	O
possibility	O
for	O
therapeutic	O
management	O
,	O
ASL	B:C0268547
deficiency	I:C0268547
is	O
part	O
of	O
the	O
recommended	O
uniform	O
screening	O
panel	O
for	O
newborn	B:C0027617
screening	I:C0027617
in	O
the	O
USA	B:C0041703
.	O

We	O
report	B:C0684224
here	O
a	O
case	O
of	O
ASL	B:C0268547
deficiency	I:C0268547
that	O
was	O
missed	O
on	O
newborn	B:C0027617
screening	I:C0027617
in	O
the	O
USA	B:C0041703
.	O

The	O
case	O
reported	O
here	O
has	O
two	O
known	O
pathogenic	B:C3816499
mutations	B:C0026882
-	O
one	O
with	O
no	B:C0243095
residual	I:C0243095
activity	I:C0243095
and	O
one	O
with	O
reported	O
10	O
%	O
residual	B:C0243095
activity	I:C0243095
.	O

Review	O
of	O
this	O
newborn	B:C0027617
screening	I:C0027617
results	O
showed	O
subtle	O
elevation	O
of	O
citrulline	B:C0008864
,	O
overlapping	O
the	O
normal	O
range	O
.	O

These	O
findings	B:C0243095
suggest	O
that	O
newborn	B:C0027617
screening	I:C0027617
may	O
be	O
missing	O
other	O
patients	O
with	O
ASL	B:C0268547
deficiency	I:C0268547
with	O
at	O
least	O
one	O
hypomorphic	B:C0002085
allele	I:C0002085
.	O

This	O
case	O
was	O
diagnosed	B:C0011900
incidentally	O
,	O
but	O
in	O
retrospect	O
had	O
symptoms	B:C1457887
best	O
attributed	O
in	O
full	O
or	O
in	O
part	O
to	O
his	O
ASA	B:C0268547
deficiency	I:C0268547
,	O
including	O
protein	B:C2673720
aversion	I:C2673720
,	O
developmental	B:C0424605
delay	I:C0424605
,	O
and	O
seizures	B:C0036572
.	O

This	O
case	O
highlights	O
the	O
importance	O
of	O
considering	O
ASL	B:C0268547
deficiency	I:C0268547
in	O
patients	O
with	O
nonspecific	B:C1457887
abnormal	I:C1457887
neurocognitive	I:C1457887
signs	I:C1457887
,	O
such	O
as	O
epilepsy	B:C0014544
and	O
developmental	B:C0424605
delay	I:C0424605
,	O
even	O
when	O
newborn	B:C0027617
screening	I:C0027617
was	O
normal	O
.	O

